Table 3. Healthcare use and complications at six to eight months after SARS-CoV-2 infection.
| Variable | Age group | Sex | Hospitalization | Overall, N = 431 | ||||
|---|---|---|---|---|---|---|---|---|
| 18–39 years, N = 164 | 40–64 years, N = 205 | ≥65 years, N = 62 | Female, N = 214 | Male, N = 217 | Non-hospitalized, N = 350 | Hospitalized, N = 81 | ||
| GP visit related to COVID-19 | 33 (20.4%) | 85 (42.7%) | 32 (53.3%) | 80 (38.5%) | 70 (32.9%) | 100 (29.2%) | 50 (63.3%) | 150 (35.6%) |
| Missing | 2 | 6 | 2 | 6 | 4 | 8 | 2 | 10 |
| Number of GP visits related to COVID-19 a | ||||||||
| 1–2 | 22 (67%) | 63 (75%) | 21 (66%) | 56 (71%) | 50 (71%) | 70 (71%) | 36 (72%) | 106 (71%) |
| 3–5 | 10 (30%) | 18 (21%) | 8 (25%) | 19 (24%) | 17 (24%) | 26 (26%) | 10 (20%) | 36 (24%) |
| ≥6 | 1 (3%) | 3 (4%) | 3 (9%) | 4 (5%) | 3 (4%) | 3 (3%) | 4 (8%) | 7 (5%) |
| Missing | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 |
| Medical hotline contact related to COVID-19 | 16 (9.8%) | 13 (6.3%) | 2 (3.3%) | 19 (8.9%) | 12 (5.6%) | 25 (7.2%) | 6 (7.4%) | 31 (7.2%) |
| Missing | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 1 |
| Number of medical hotline contacts related to COVID-19a | ||||||||
| 1–2 | 14 (88%) | 7 (70%) | 2 (100%) | 15 (88%) | 8 (73%) | 18 (78%) | 5 (100%) | 23 (82%) |
| 3–5 | 2 (12%) | 3 (30%) | 0 (0%) | 2 (12%) | 3 (27%) | 5 (22%) | 0 (0%) | 5 (18%) |
| ≥6 | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
| Missing | 0 | 3 | 0 | 2 | 1 | 2 | 1 | 3 |
| Rehospitalizations related to COVID-19 (N = 81) | 1 (10%) | 3 (7%) | 4 (14%) | 4 (11%) | 4 (10%) | - | 8 (10%) | 8 (10%) |
| Number of rehospitalizations related to COVID-19 a | ||||||||
| 1 | 0 (0%) | 3 (100%) | 4 (100%) | 3 (75%) | 4 (100%) | - | 7 (88%) | 7 (88%) |
| 2–3 | 1 (100%) | 0 (0%) | 0 (0%) | 1 (25%) | 0 (0%) | - | 1 (12%) | 1 (12%) |
| GP visit or rehospitalization related to COVID-19 | 34 (21.0%) | 85 (42.7%) | 33 (55.0%) | 82 (39.4%) | 70 (32.9%) | 100 (29.2%) | 52 (65.8%) | 152 (36.1%) |
| Missing | 2 | 6 | 2 | 6 | 4 | 8 | 2 | 10 |
| Healthcare contact related to COVID-19 | 45 (27.8%) | 92 (46.2%) | 33 (55.0%) | 94 (45.2%) | 76 (35.7%) | 116 (33.9%) | 54 (68.4%) | 170 (40.4%) |
| Missing | 2 | 6 | 2 | 6 | 4 | 8 | 2 | 10 |
| New medical diagnoses | 12 (7.3%) | 47 (22.9%) | 18 (29.0%) | 36 (16.8%) | 41 (18.9%) | 43 (12.3%) | 34 (42.0%) | 77 (17.9%) |
| Type of new medical diagnosis b | ||||||||
| COVID-19 related complication (medically evaluated) | 2 (17%) | 17 (36%) | 8 (44%) | 12 (33%) | 15 (37%) | 12 (28%) | 15 (44%) | 27 (35%) |
| COVID-19 related complication (self-evaluated) | 3 (25%) | 6 (13%) | 2 (11%) | 6 (17%) | 5 (12%) | 7 (16%) | 4 (12%) | 11 (14%) |
| Non COVID-19 related diagnosis or unclear | 7 (58%) | 24 (51%) | 8 (44%) | 18 (50%) | 21 (51%) | 24 (56%) | 15 (44%) | 39 (51%) |
DASS-21 = Depression, Anxiety and Stress Score (21 items), EQ = EuroQol, FAS = Fatigue Assessment Scale, GP = General Practitioner, IQR = Interquartile Range, mMRC = modified Medical Research Council, VAS = Visual Analogue Scale.
a percentage within each category of healthcare contact (general practitioner visit, medical hotline call, rehospitalisation),
b percentage among all medical diagnoses.